SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Cardiovascular Pharmacology and Therapeutics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Heywood, J. T.
Right arrow Articles by Huiskes, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heywood, J. T.
Right arrow Articles by Huiskes, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Simple Clinical Criteria to Determine the Prognosis of Heart Failure

J. Thomas Heywood, MD

Department of Cardiology, Loma Linda University Medical Center, Loma Linda, CA

Wafaa Elatre, MD, MPH

Department of Cardiology, Loma Linda University Medical Center, Loma Linda, CA

Ramdas G. Pai, MD

Department of Cardiology, Loma Linda University Medical Center, Loma Linda, CA

Sharon Fabbri, RMP

Department of Cardiology, Loma Linda University Medical Center, Loma Linda, CA

Bonnie Huiskes, FNP

Department of Cardiology, Loma Linda University Medical Center, Loma Linda, CA

Objective: To determine whether easily obtained clinical parameters serve as predictors of survival in patients with congestive heart failure. Several scoring systems to predict heart failure survival have been developed; however, many of these deal principally with transplant recipients or do not account for a patient’s response to therapy.

Methods: A total of 680 patients with an ejection fraction of less than 40% were included in the analysis. Baseline assessments were performed and treatment regimens were identified; patients were then followed for up to 5 years. Univariate and multivariate Cox regression models were used to determine clinically important predictors of survival. Kaplan-Meier survival functions for patients with and without the prognostic variable were constructed and mortality was calculated at 1 year and 5 years.

Results: Ejection fraction improvement at 6 months, diabetes mellitus, age, serum creatinine, and blood urea nitrogen (BUN) were significant predictors for survival in the univariate model. Ejection fraction improvement, age, and BUN were significant predictors in the multivariate model. These findings were used to construct a model for predicting patient mortality. Improved ejection fraction (>15 ejection fraction units) gave a 1-year mortality of 2% and a 5-year mortality of 11%. Mortality rates according to patient age and BUN levels were also calculated.

Conclusion: Ejection fraction improvement was the most important predictor for survival in patients with systolic dysfunction; monitoring ejection fraction changes through repeat echocardiograms has important prognostic value. In patients without ejection fraction improvement, age and renal function are important survival determinants.

Key Words: clinical parameters • heart failure • ejection fraction

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 10, No. 3, 173-180 (2005)
DOI: 10.1177/107424840501000305


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Eur J Heart FailHome page
H. Wedel, J. J.V. McMurray, M. Lindberg, J. Wikstrand, J. G.F. Cleland, J. H. Cornel, P. Dunselman, A. Hjalmarson, J. Kjekshus, M. Komajda, et al.
Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide
Eur J Heart Fail, March 1, 2009; 11(3): 281 - 291.
[Abstract] [Full Text] [PDF]


Home page
Chronic IllnessHome page
S. Barnes, M. Gott, S. Payne, C. Parker, D. Seamark, S. Gariballa, and N. Small
Predicting mortality among a general practice-based sample of older people with heart failure
Chronic Illness, March 1, 2008; 4(1): 5 - 12.
[Abstract] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
D. Chen, R. Chang, B. Umakanthan, L. N. Stoletniy, and J. T. Heywood
Improvement of Cardiac Function Persists Long Term With Medical Therapy for Left Ventricular Systolic Dysfunction
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2007; 12(3): 220 - 226.
[Abstract] [PDF]



Advertisement